下调PRPS2基因表达对HCT116细胞增殖和凋亡的影响

doi:10.3969/j.issn.1004-616x.2015.02.006

癌变·畸变·突变 ›› 2015, Vol. 27 ›› Issue (2): 106-110.doi: 10.3969/j.issn.1004-616x.2015.02.006

下调PRPS2基因表达对HCT116细胞增殖和凋亡的影响

许雅鑫¹, 李钰², 吴彬³, 游锦梅⁴, Yang Yong⁵, 陈显久⁴

1. 山西医科大学流行病学教研室, 山西太原 030001;
2. 山西医科大学第一医院骨科, 山西太原 030001;
3. 太原钢铁集团有限公司总医院中心实验室, 山西太原 030003;
4. 山西医科大学生物化学与分子生物学教研室, 山西太原 030001;
5. 新加坡中央医院医疗委员会流行病科, 新加坡 169608

收稿日期:2014-06-12 修回日期:2015-01-29 出版日期:2015-03-31 发布日期:2015-03-31
通讯作者: 陈显久,Tel:17835100555
作者简介:许雅鑫,E-mail:xu_ya_xin@sina.com;李钰,E-mail:329691788@qq.com。
基金资助:
山西省科技(工业)攻关项目基金资助(20110321076-02);山西省国际科技合作项目基金资助(2012081050-1)

Effects of down-regulated PRPS2 gene expression on HCT116 cell proliferation and apoptosis

XU Yaxin¹, LI Yu², WU Bin³, YOU Jinmei⁴, YANG Yong⁵, CHEN Xianjiu⁴

1. Department of Epidemiololgy, Shanxi Medical University, Taiyuan 030001;
2. Department of Orthopedics, First Hospital of Shanxi Medical University, Taiyuan 030001;
3. Department of Central Laboratory, General Hospital of TISCO, Taiyuan 030003;
4. Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan 030001, Shanxi, China;
5. Department of Epidemiology, Medical Board, Singapore General Hospital, Singapore 169608

Received:2014-06-12 Revised:2015-01-29 Online:2015-03-31 Published:2015-03-31
About author:10.3969/j.issn.1004-616x.2015.02.006

摘要/Abstract

摘要：

目的:探讨下调磷酸核糖焦磷酸合成酶亚基II(PRPS2)基因表达对人结肠癌HCT116细胞增殖和凋亡的影响。方法:构建PRPS2基因干扰载体sh-PRPS2,正常对照组不转染载体,阴性对照组转染阴性对照载体sh-PRPS2-0,3个实验组分别转染干扰载体sh-PRPS2-1、sh-PRPS2-2和sh-PRPS2-3,经DNA测序鉴定后转染人结肠癌HCT116细胞,分别采用RT-PCR和Western blot法检测各载体转染后细胞PRPS2 mRNA和蛋白水平的表达变化,CCK8试剂盒检测细胞增殖能力,流式细胞术检测细胞周期及凋亡的变化。结果:经DNA测序证实成功构建sh-PRPS2干扰载体3个,分别为sh-PRPS2-1、sh-PRPS2-2和sh-PRPS2-3。将上述3个干扰载体分别转染HCT116细胞72 h后,RT-PCR结果显示,PRPS2 mRNA相对表达量依次为0.61±0.03、0.89±0.02、0.27±0.05,与对照组比较,均显著下降(P<0.05)。Western blot结果显示,PRPS2蛋白相对表达量依次为0.37±0.06、0.84±0.05、0.30±0.04,与对照组比较均显著下降(P<0.05)。转染sh-PRPS2-3载体72 h后细胞增殖抑制率达19.8%±2.4%,凋亡率上升至68.4%±4.6%,G0/G1期细胞比例上升为12.9%±3.8%。结论:PRPS2的低表达可以有效抑制细胞增殖,促进细胞凋亡,细胞阻滞于G0/G1期,本研究为肿瘤的靶向治疗提供了研究基础。

关键词: 磷酸核糖焦磷酸合成酶亚基II, RNA干扰, HCT116细胞, 结肠癌

Abstract:

OBJECTIVE:To investigate the effects on HCT116 cell proliferation and apoptosis by down-regulating PRPS2 gene expression. METHODS:PRPS2 gene interference vector sh-PRPS2 was constructed. The vector was not the transfected in normal control;the negative vector was transfected in negative control and the RNAi vector was transfected in experimental groups. The vectors were transfected to HCT116 cells after identified by DNA sequencing, and the level of PRPS2 mRNA and protein were detected by RT-PCR and Western blot, respectively. The ability of cell proliferation was evaluated by CCK8 kit. The cell cycle and apoptosis were assessed by flow cytometry. RESULTS:The RNAi expression vector of PRPS2 was successfully constructed as identified by DNA sequencing:sh-PRPS2-1, sh-PRPS2-2 and sh-PRPS2-3. The relative expression levels of PRPS2 mRNA were 0.61±0.03, 0.89±0.02 and 0.27±0.05 in HCT116 cells 72 h after transfected with sh-PRPS2-1, sh-PRPS2-2 and sh-PRPS2-3, respectively, all decreased significantly compared with control (P<0.05). The relative expression levels of PRPS2 protein were 0.37±0.06, 0.84±0.05 and 0.30±0.04, respectively, and also decreased significantly compared with control (P<0.05). 72 h after transfection, the inhibition rate of sh-PRPS2-3 proliferation was 19.8%±2.4%. The apoptosis rate of HCT116 cell was increased to 68.4%±4.6% 72 h post transfection. Sub-G1 population percentage was increased to 12.9%±3.8%. CONCLUSION: Down-regulation of PRPS2 expression level could effectively inhibit cell proliferation as well as promote apoptosis. HCT116 cell was arrested in G0/G1 phase. This study provided a research basis for tumor targeted therapy.

Key words: PRPS2, RNA interfere, HCT116 cell, colon cancer

中图分类号:

R730.2

许雅鑫, 李钰, 吴彬, 游锦梅, Yang Yong, 陈显久. 下调PRPS2基因表达对HCT116细胞增殖和凋亡的影响[J]. 癌变·畸变·突变, 2015, 27(2): 106-110.

XU Yaxin, LI Yu, WU Bin, YOU Jinmei, YANG Yong, CHEN Xianjiu. Effects of down-regulated PRPS2 gene expression on HCT116 cell proliferation and apoptosis[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2015, 27(2): 106-110.

参考文献

[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2):69-90.
[2] 吴菲, 林国桢, 张晋昕. 我国恶性肿瘤发病现状及趋势[J]. 中国肿瘤, 2012, 21(2):81-85.
[3] SONG EW. The Biological Principles and Application of RNA Interference:Vol 1[M]. Beijing:Higher Education Press, 2005:66-72.
[4] 李建忠, 袁慧军, 韩东一. PRPS1基因突变与遗传性耳聋[J]. 中华耳科学杂志, 2010, 8(1):57-62.
[5] 尹艳慧, 朱迅. PRPS2 基因启动子区的单核苷酸多态性[J]. 中国生物化学与分子生物学报, 2003, 19(5):563-565.
[6] Amarzguioui M, Prydz H. An algorithm for selection of functional siRNA sequences[J]. Biochem Biophys Res Commun, 2004, 316(4):1050-1058.
[7] Chen X, Dudgeon N, Shen L, et al. Chemical modification of gene silencing oligonucleotides for drug discovery and development[J]. Drug Discov Today, 2005, 10(8):587-593.
[8] Gilmore IR, Fox SP, Hollins AJ, et al. The design and exogenous delivery of siRNA for post-transcriptional gene silencing[J]. J Drug Target, 2004, 12(6):315-340.
[9] Yamano S, Dai J, Moursi AM. Comparison of transfection efficiency of nonviral gene transfer reagents[J]. Mol Biotechnol, 2010, 46(3):287-300.
[10] Mannava S, Grachtchouk V, Wheeler LJ, et al. Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells[J]. Cell Cycle, 2008, 7(15):2392-2400.
[11] Ye Q, Feng B, Peng YF, et al. Expression of gamma-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116[J]. World J Gastroenterol, 2009, 15(40):5035-5043.
[12] Tang D, Kang R, Cheh CW, et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells[J]. Oncogene, 2010, 29(38):5299-5310.
[13] 李贵新, 刘锦, 李肖燕, 等. 结肠癌患者术后化疗联合自体级联诱发免疫细胞治疗近期疗效和生活质量观察[J]. 中华肿瘤防治杂志, 2014, 21(19):1548-1552.
[14] Kim D, Rossi J. RNAi mechanisms and applications[J]. Biotechniques, 2008, 44:613-616.
[15] Lin Y, Peng S, Yu H, et al. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells[J]. Med Oncol, 2012, 29(1):311-317.
[16] Noh KH1, Kim SH2, Kim JH, et al. API5 confers tumoral immune escape through FGF2-dependent cell survival pathway [J]. Cancer Res, 2014, 74(13):3556-3566.

下调PRPS2基因表达对HCT116细胞增殖和凋亡的影响

Effects of down-regulated PRPS2 gene expression on HCT116 cell proliferation and apoptosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杜璐, 姜晓燕, 丁库克. 稳定敲降NF-YB基因HeLa细胞系的构建[J]. 癌变·畸变·突变, 2020, 32(6): 409-413.
[2]	杨兴肖, 张雪原, 邹乃祎, 单保恩, 马鸣, 祝淑钗. HMGB1 siRNA干扰对食管鳞癌细胞放射敏感性的影响[J]. 癌变·畸变·突变, 2020, 32(4): 269-274.
[3]	李欣欣, 廖伟南, 庄少惠, 陈焕杰, 陈君填, 章斐然, 李威. 白介素17与上皮间质转化相关标志物在左右半结肠癌中的表达及其意义[J]. 癌变·畸变·突变, 2019, 31(4): 315-318.
[4]	陆建荣，丁彩霞，袁勇，张娟，蔡琳. Axin通过激活p53的表达抑制结肠癌细胞的生长[J]. 癌变·畸变·突变, 2014, 26(5): 330-333.
[5]	李秀梅，李卉，姜孝芳，陈艳，湛宏鸣，李惠武. Survivin shRNA干扰对食管癌细胞CDK4 mRNA表达的影响[J]. 癌变·畸变·突变, 2014, 26(4): 298-304.
[6]	牛永东，陈理明，吴曼鹏，程訸，徐涵，高分飞，石刚刚. 慢病毒介异的孕烷X受体sh-RNA稳定干扰HepG2细胞株的构建[J]. 癌变·畸变·突变, 2014, 26(3): 209-212.
[7]	申艳梅,单保恩,刘丽华,张超,周凯旋,焦煜倩,焦文静. HSP70多肽复合物的抗肿瘤作用研究[J]. 癌变·畸变·突变, 2013, 25(4): 262-266.
[8]	许小琴,宋学雄,黄天华. shRNA在抗猪瘟病毒中稳定遗传表达的研究进展[J]. 癌变·畸变·突变, 2013, 25(3): 239-243.
[9]	刘建军,蒋英芝,叶金波,李杰,杨细飞,周丽,黄海燕,黄新凤. SET基因shRNA慢病毒载体的构建及其在肝细胞中的表达鉴定[J]. 癌变·畸变·突变, 2013, 25(1): 44-47.
[10]	王媛媛1/宋光2/李玉梅1/吕洪波1. 与结肠癌转移倾向相关的细胞粘附基因的筛查[J]. 癌变·畸变·突变, 2012, 24(6): 418-421.
[11]	景绍武;王雅棣;郑明民;孙国贵;刘青;程云杰;杨从容;李成林. RNA干扰HIF-1 α 对低氧状态下食管鳞癌Eca109细胞放射敏感性的影响[J]. 癌变·畸变·突变, 2012, 24(5): 325-329.
[12]	毛吉炎;徐新云;何晓阳;毛侃琅;黄海燕;刘庆成. CYP2E1基因RNA 干扰载体的构建与表达[J]. , 2012, 24(4): 290-294.
[13]	陈宝安，张文静，张孝平，柏志斌，冯继峰，仲悦娇，丁家华，高冲，鲍文，彭苗新，程璐，陆祖宏. 应用质谱技术检测结肠癌细胞DPYD和MTHFR基因单核苷酸多态性[J]. , 2012, 24(2): 96-99.
[14]	李湛军,林飞,范慧红,徐康森. 血清胸腺因子9肽对人结肠癌HT-29的抑瘤作用[J]. , 2011, 23(5): 374-376.
[15]	刘冬玲(综述),黄天华*(审校). RNA干扰抑制乙型肝炎病毒研究进展[J]. , 2011, 23(3): 242-.